Carvedilol Tablet, Film Coated
Product Images NDC 42708-181

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 42708-181). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

42708-181-60 (42708 181 60 Label)

Label for Carvedilol Tablets USP 3.125 mg film-coated tablets, packaged as 60 tablets. The label includes directions for dosage, storage instructions to keep at controlled room temperature, and warnings to keep the container tightly closed and out of reach of children. The labeler is QPharma Inc. and it includes a product NDC barcode.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)

Chemical structure of Carvedilol, showing its molecular arrangement including indole and methoxyphenyl groups connected by a side chain with hydroxyl and amine functionalities.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)

A line graph showing percent mortality over time in months for two groups: Placebo and Carvedilol. The graph depicts mortality increasing over 21 months, with Carvedilol showing a lower percent mortality compared to Placebo. A p-value of 0.0014 is displayed indicating statistical comparison between the two groups.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)

A forest plot chart showing hazard ratios with 95% confidence intervals for various subgroups including sex (men, women), age (<65, ≥65), race (non-black, black), diabetic status, ischemic status, heart rate, systolic blood pressure categories, and spironolactone use, along with all patients combined. The x-axis represents the hazard ratio ranging from 0.0 to 2.0.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)

A line graph comparing the percentage mortality over 24 months between two groups labeled 'Placebo' and 'Carvedilol'. The vertical axis shows percentage mortality from 0 to 30%, and the horizontal axis represents time in months from 0 to 24. The graph indicates lower mortality in the Carvedilol group compared to the Placebo group, with a P-value of 0.03.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)

A forest plot chart depicting hazard ratios for various subgroups in a study. Variables include age groups, sex, MI timing, beta-blocker history, Killip class, thrombolytic use, PTCA for MI, heart failure status, angina, hypertension, diabetes, heart rate, and systolic blood pressure. The chart shows hazard ratio points with confidence intervals for each subgroup comparison.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.